Cost Effectiveness Analysis of Critical Care in Resource Limited Setting
NCT ID: NCT02556476
Last Updated: 2015-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
148 participants
OBSERVATIONAL
2011-06-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main study hypothesis was that critical care is cost effective in low resources setting.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Burden, Mortality and Supply Costs in Intensive Care Unit Patients
NCT04094428
Factors Associated With Early Readmission in Critical Care
NCT07182916
Mortality in Cancer Patients Admitted to the Intensive Care Unit in a Resource-limited Setting
NCT02659839
The Effect of Applying Modified NUTRIC Scoring System to Evaluate the Nutrition Risk and Giving Different Types of Nutritional Support on Clinical Outcomes in Critically Ill Patients
NCT03365258
Socioeconomic Factors and Mortality in the Intensive Care Population
NCT06554808
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: Consecutive critically ill medical patients treated in a recently established medical ICU in Sarajevo, Bosnia and Herzegovina, were prospectively recorded and a subsequent cost utility analysis of intensive care in comparison to hospital ward treatment from the perspective of health care system was performed. Incremental cost effectiveness was calculated using estimates of ICU versus non-ICU treatment effectiveness based on a formal systematic review of published studies. Decision analytic modeling was used to compare treatment alternatives. Sensitivity analyses of the key model parameters were performed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICU patients
The actual cohort of 148 critically ill medical patients that received the treatment in the intensive care unit (ICU). The interventions include interventions that are usually performed within the ICU such as mechanical ventilation, non-invasive ventilation, neuromuscular blockade, renal replacement therapy.
mechanical ventilation
ventilator support for the patients presenting with acute respiratory failure
neuromuscular blockade
paralysis of the skeletal muscles in order to optimize mechanical ventilation, especially during ARDS
renal replacement therapy
the procedures used to treat acute kidney injury
non-invasive ventilation
Procedure used for ventilation support in patients with congestive heart failure, pulmonary edema, COPD and some other conditions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mechanical ventilation
ventilator support for the patients presenting with acute respiratory failure
neuromuscular blockade
paralysis of the skeletal muscles in order to optimize mechanical ventilation, especially during ARDS
renal replacement therapy
the procedures used to treat acute kidney injury
non-invasive ventilation
Procedure used for ventilation support in patients with congestive heart failure, pulmonary edema, COPD and some other conditions.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* hospital readmissions
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sarajevo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hajrunisa Cubro
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hajrunisa Cubro, MD
Role: PRINCIPAL_INVESTIGATOR
Medical ICU University of Sarajevo Clinical Center, Sarajevo, Bosnia and Herzegovina
Ognjen Gajic, MD, MSc
Role: STUDY_CHAIR
Division of Pulmonary and Critical Care Mayo Clinic Rochester MN USA
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCUS-2435/11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.